Replies to post #51246 on $heff's $tation of $tocks & $olid DD

[Investor100]

CBRX:Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%

PPS:.79

PARSIPPANY and LIVINGSTON, N.J., Feb. 27, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI - News) and Columbia Laboratories, Inc. (Nasdaq: CBRX - News) today confirmed that, as expected, Watson has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA 22-139) for progesterone vaginal gel 8% for use in the reduction of risk of preterm birth in women with a singleton gestation and a short uterine cervical length in the mid-trimester of pregnancy.

http://finance.yahoo.com/news/Watson-Receives-Complete-prnews-583477954.html?x=0

Investor 100